Alwin Capital
Beijing, Beijingalwincapital.com
Overview
Alwin Capital is a venture capital firm in China specializing in early-stage life science investments . Driven by theme-focused research in life science, Alwin Capital has developed investment strategies that capture outstanding opportunities for innovative diagnostic and therapeutic developments . The firm is committed to long-term investment in life science with the pursuit of excess investment return based on scientific insights . Alwin Capital has formed a systematic investment layout covering Innovative Drugs, Molecular Diagnostics, Innovative Hardware, Scientific Services and AI Applications .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SEEHO Medical Equipment & Vehicles Co., Ltd. | Jul 2026 | Series B Extension | Lead |
| Nanjing Polymer Medical Technology Co., Ltd. | Jul 2025 | Series C | Co-investor |
| BioLink | Nov 2024 | Strategic | Co-investor |
| ICE Bioscience | May 2024 | Series B++ | Co-investor |
| Sanegene Bio | Dec 2023 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
